Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
1.41
0.03 (2.17%)
At close: Oct 03, 2025, 3:59 PM
1.44
2.12%
After-hours: Oct 03, 2025, 07:58 PM EDT
2.17% (1D)
| Bid | 1.37 |
| Market Cap | 512.39M |
| Revenue (ttm) | 58.43M |
| Net Income (ttm) | -120.62M |
| EPS (ttm) | -0.32 |
| PE Ratio (ttm) | -4.41 |
| Forward PE | -5.11 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.49 |
| Volume | 2,230,793 |
| Avg. Volume (20D) | 2,737,787.4 |
| Open | 1.40 |
| Previous Close | 1.38 |
| Day's Range | 1.39 - 1.46 |
| 52-Week Range | 0.28 - 2.17 |
| Beta | 1.24 |
| Ex-Dividend Date | n/a |
About LXRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LXRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LXRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLexicon Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+9.52%
LXRX stock has given up its prior loss. Lexicon Ph...
Unlock content with
Pro Subscription
2 months ago
+9.52%
Lexicon Pharmaceuticals shares are trading lower following the release of its Q2 financial results.
2 months ago · fool.com
Lexicon (LXRX) Q2 Revenue Soars 1,706%Lexicon (LXRX) Q2 Revenue Soars 1,706%
